Clinical Trial Update: Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide in combination with bevacizumab for stage IV melanoma that cannot be surgically removed has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Avastin (bevacizumab)
• Temodar (Temozolomide)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED